DR-0202

· Dren Bio

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DR-0202, covering 2026-01-07 to 2026-01-07. Get the full timeline:

Most recent: Clinical Trial Update: A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas [Phase 1]